These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37820941)
1. Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy. Saleh Faisal M; Jamil A; Ali N; Alshahrani AM; Almarshad F Gene; 2024 Jan; 892():147886. PubMed ID: 37820941 [TBL] [Abstract][Full Text] [Related]
2. Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy. Guo Y; Hu C; He X; Qiu F; Zhao L Drug Metab Pharmacokinet; 2012; 27(5):536-42. PubMed ID: 23099353 [TBL] [Abstract][Full Text] [Related]
3. Impact of MDR1 and UGT Gene Polymorphisms on Sodium Valproate Plasma Concentration in Patients with Epilepsy. Song C; Li X; Zhang H; Bao J; Lu W; Peng Q; Zhang Y Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250837 [TBL] [Abstract][Full Text] [Related]
4. Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. Chu XM; Zhang LF; Wang GJ; Zhang SN; Zhou JH; Hao HP Eur J Clin Pharmacol; 2012 Oct; 68(10):1395-401. PubMed ID: 22476391 [TBL] [Abstract][Full Text] [Related]
5. Correlations between UGT2B7ā2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients. Zhang H; Zhang W; Li Y; Yan J; Zhang J; Wang B Brain Dev; 2018 Feb; 40(2):100-106. PubMed ID: 28958730 [TBL] [Abstract][Full Text] [Related]
6. Effect of UGT2B7 genetic variants on serum valproic acid concentration. Ma H; Zhang T; Gong Z; Zhou B; Zou M; Xiao S; Zhu W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):766-72. PubMed ID: 23981985 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of UGT1A6 polymorphisms in children with epilepsy on valproate monotherapy. Jain P; Shastri S; Gulati S; Kaleekal T; Kabra M; Gupta N; Gupta YK; Pandey RM Neurol India; 2015; 63(1):35-9. PubMed ID: 25751467 [TBL] [Abstract][Full Text] [Related]
8. UGT1A6 and UGT2B7 Gene Polymorphism and its Effect in Pediatric Epileptic Patients on Sodium Valproate Monotherapy. Nandith PB; Adiga U; Shenoy V; Adiga M N S Indian J Pediatr; 2021 Aug; 88(8):764-770. PubMed ID: 33400134 [TBL] [Abstract][Full Text] [Related]
9. The influence of UGT2B7 genotype on valproic acid pharmacokinetics in Chinese epilepsy patients. Sun YX; Zhuo WY; Lin H; Peng ZK; Wang HM; Huang HW; Luo YH; Tang FQ Epilepsy Res; 2015 Aug; 114():78-80. PubMed ID: 26088889 [TBL] [Abstract][Full Text] [Related]
10. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis. Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113 [TBL] [Abstract][Full Text] [Related]
11. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
12. Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161Cā>āT and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children. Liu L; Zhao L; Wang Q; Qiu F; Wu X; Ma Y Eur J Clin Pharmacol; 2015 Nov; 71(11):1341-7. PubMed ID: 26303110 [TBL] [Abstract][Full Text] [Related]
13. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884 [TBL] [Abstract][Full Text] [Related]
14. Influence of uridine diphosphate glucuronosyltransferase 2B7 -161C>T polymorphism on the concentration of valproic acid in pediatric epilepsy patients. Inoue K; Suzuki E; Yazawa R; Yamamoto Y; Takahashi T; Takahashi Y; Imai K; Koyama S; Inoue Y; Tsuji D; Hayashi H; Itoh K Ther Drug Monit; 2014 Jun; 36(3):406-9. PubMed ID: 24365988 [TBL] [Abstract][Full Text] [Related]
15. Influence of Du Z; Xu H; Zhao P; Wang J; Xu Q; Liu M Xenobiotica; 2021 Jul; 51(7):859-864. PubMed ID: 34000957 [TBL] [Abstract][Full Text] [Related]
16. Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. Wang P; Yin T; Ma HY; Liu DQ; Sheng YH; Wang C; Zhou BT Epilepsy Res; 2015 Nov; 117():52-7. PubMed ID: 26421491 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of microsomal epoxide hydrolase and UDP-glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross-sectional genetic association study. Venkatraman S; Ramasamy K; Nair PP Indian J Pharmacol; 2023; 55(3):149-154. PubMed ID: 37555408 [TBL] [Abstract][Full Text] [Related]
18. The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach. Munisamy M; Tripathi M; Behari M; Raghavan S; Jain DC; Ramanujam B; Arumugam K; Rajakannan T; Mallayasamy SR; Subbiah V Mol Diagn Ther; 2013 Oct; 17(5):319-26. PubMed ID: 23749495 [TBL] [Abstract][Full Text] [Related]
19. Association of UGT1A6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy. Yin Z; Li P Seizure; 2024 Aug; 120():56-60. PubMed ID: 38908142 [TBL] [Abstract][Full Text] [Related]
20. Impact of Age and Genotype on Serum Concentrations of Valproic Acid and Its Hepatotoxic Metabolites in Chinese Pediatric Patients With Epilepsy. Zhao M; Chen Y; Wang M; Li G; Zhao L Ther Drug Monit; 2020 Oct; 42(5):760-765. PubMed ID: 32107351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]